Menu

Four major insulin manufacturers recently urged the U.S. 2nd Circuit Court of Appeals to reconsider its August decision in an antitrust class action lawsuit against them.

Drugmakers Ask 2nd Circuit to Reconsider Antitrust Case Decision, Delaying Return to District Court

November 4, 2025 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Four major insulin manufacturers recently urged a federal appeals court to reconsider its August decision in an antitrust class action [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Oklahoma Attorney General Plans to Appeal Federal Judge’s Ruling Blocking 340B Contract Pharmacy Law

Beacon Posts Drugmaker 340B Rebate Implementation Plans, Then Changes Rebate FAQs—Drawing Provider Frustration